Cargando…

Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling

The acetylcholinesterase inhibitors donepezil and rivastigmine have been used as therapeutic drugs for Alzheimer’s disease (AD), but their effects on LPS- and Aβ-induced neuroinflammatory responses and the underlying molecular pathways have not been studied in detail in vitro and in vivo. In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jieun, Lee, Hyun-ju, Park, Seon Kyeong, Park, Jin-Hee, Jeong, Ha-Ram, Lee, Soojung, Lee, Heeyong, Seol, Eunyoung, Hoe, Hyang-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508964/
https://www.ncbi.nlm.nih.gov/pubmed/34638977
http://dx.doi.org/10.3390/ijms221910637
_version_ 1784582222536245248
author Kim, Jieun
Lee, Hyun-ju
Park, Seon Kyeong
Park, Jin-Hee
Jeong, Ha-Ram
Lee, Soojung
Lee, Heeyong
Seol, Eunyoung
Hoe, Hyang-Sook
author_facet Kim, Jieun
Lee, Hyun-ju
Park, Seon Kyeong
Park, Jin-Hee
Jeong, Ha-Ram
Lee, Soojung
Lee, Heeyong
Seol, Eunyoung
Hoe, Hyang-Sook
author_sort Kim, Jieun
collection PubMed
description The acetylcholinesterase inhibitors donepezil and rivastigmine have been used as therapeutic drugs for Alzheimer’s disease (AD), but their effects on LPS- and Aβ-induced neuroinflammatory responses and the underlying molecular pathways have not been studied in detail in vitro and in vivo. In the present study, we found that 10 or 50 μM donepezil significantly decreased the LPS-induced increases in the mRNA levels of a number of proinflammatory cytokines in BV2 microglial cells, whereas 50 μM rivastigmine significantly diminished only LPS-stimulated IL-6 mRNA levels. In subsequent experiments in primary astrocytes, donepezil suppressed only LPS-stimulated iNOS mRNA levels. To identify the molecular mechanisms by which donepezil regulates LPS-induced neuroinflammation, we examined whether donepezil alters LPS-stimulated proinflammatory responses by modulating LPS-induced downstream signaling and the NLRP3 inflammasome. Importantly, we found that donepezil suppressed LPS-induced AKT/MAPK signaling, the NLRP3 inflammasome, and transcription factor NF-kB/STAT3 phosphorylation to reduce neuroinflammatory responses. In LPS-treated wild-type mice, a model of neuroinflammatory disease, donepezil significantly attenuated LPS-induced microglial activation, microglial density/morphology, and proinflammatory cytokine COX-2 and IL-6 levels. In a mouse model of AD (5xFAD mice), donepezil significantly reduced Aβ-induced microglial and astrocytic activation, density, and morphology. Taken together, our findings indicate that donepezil significantly downregulates LPS- and Aβ-evoked neuroinflammatory responses in vitro and in vivo and may be a therapeutic agent for neuroinflammation-associated diseases such as AD.
format Online
Article
Text
id pubmed-8508964
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85089642021-10-13 Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling Kim, Jieun Lee, Hyun-ju Park, Seon Kyeong Park, Jin-Hee Jeong, Ha-Ram Lee, Soojung Lee, Heeyong Seol, Eunyoung Hoe, Hyang-Sook Int J Mol Sci Article The acetylcholinesterase inhibitors donepezil and rivastigmine have been used as therapeutic drugs for Alzheimer’s disease (AD), but their effects on LPS- and Aβ-induced neuroinflammatory responses and the underlying molecular pathways have not been studied in detail in vitro and in vivo. In the present study, we found that 10 or 50 μM donepezil significantly decreased the LPS-induced increases in the mRNA levels of a number of proinflammatory cytokines in BV2 microglial cells, whereas 50 μM rivastigmine significantly diminished only LPS-stimulated IL-6 mRNA levels. In subsequent experiments in primary astrocytes, donepezil suppressed only LPS-stimulated iNOS mRNA levels. To identify the molecular mechanisms by which donepezil regulates LPS-induced neuroinflammation, we examined whether donepezil alters LPS-stimulated proinflammatory responses by modulating LPS-induced downstream signaling and the NLRP3 inflammasome. Importantly, we found that donepezil suppressed LPS-induced AKT/MAPK signaling, the NLRP3 inflammasome, and transcription factor NF-kB/STAT3 phosphorylation to reduce neuroinflammatory responses. In LPS-treated wild-type mice, a model of neuroinflammatory disease, donepezil significantly attenuated LPS-induced microglial activation, microglial density/morphology, and proinflammatory cytokine COX-2 and IL-6 levels. In a mouse model of AD (5xFAD mice), donepezil significantly reduced Aβ-induced microglial and astrocytic activation, density, and morphology. Taken together, our findings indicate that donepezil significantly downregulates LPS- and Aβ-evoked neuroinflammatory responses in vitro and in vivo and may be a therapeutic agent for neuroinflammation-associated diseases such as AD. MDPI 2021-09-30 /pmc/articles/PMC8508964/ /pubmed/34638977 http://dx.doi.org/10.3390/ijms221910637 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Jieun
Lee, Hyun-ju
Park, Seon Kyeong
Park, Jin-Hee
Jeong, Ha-Ram
Lee, Soojung
Lee, Heeyong
Seol, Eunyoung
Hoe, Hyang-Sook
Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
title Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
title_full Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
title_fullStr Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
title_full_unstemmed Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
title_short Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
title_sort donepezil regulates lps and aβ-stimulated neuroinflammation through mapk/nlrp3 inflammasome/stat3 signaling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508964/
https://www.ncbi.nlm.nih.gov/pubmed/34638977
http://dx.doi.org/10.3390/ijms221910637
work_keys_str_mv AT kimjieun donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling
AT leehyunju donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling
AT parkseonkyeong donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling
AT parkjinhee donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling
AT jeongharam donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling
AT leesoojung donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling
AT leeheeyong donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling
AT seoleunyoung donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling
AT hoehyangsook donepezilregulateslpsandabstimulatedneuroinflammationthroughmapknlrp3inflammasomestat3signaling